1994
DOI: 10.1161/01.atv.14.5.701
|View full text |Cite
|
Sign up to set email alerts
|

The association of hypotestosteronemia with coronary artery disease in men.

Abstract: Hyperestrogenemia and hypotestosteronemia have been observed in association with myocardial infarction (MI) and its risk factors. To determine whether these abnormalities may be prospective for MI, estradiol and testosterone, as well as risk factors for MI, were measured in 55 men undergoing angiography who had not previously had an MI. Testosterone (r=-.36, /"=.008) and free testosterone (r=-A9, P<.001) correlated negatively with the degree of coronary artery disease after controlling for age and body mass in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

13
177
2
10

Year Published

2000
2000
2014
2014

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 361 publications
(206 citation statements)
references
References 47 publications
13
177
2
10
Order By: Relevance
“…Estimates from this study are nationally representative of the U.S. adult male population in 1988 -1991. METHODS -Between 1988 and1994, the National Center for Health Statistics conducted the Third National Health and Nutrition Examination Survey (NHANES III). NHANES III was designed as a cross-sectional study using a multistage-stratified, clustered probability sample of the U.S. civilian noninstitutionalized population.…”
mentioning
confidence: 99%
“…Estimates from this study are nationally representative of the U.S. adult male population in 1988 -1991. METHODS -Between 1988 and1994, the National Center for Health Statistics conducted the Third National Health and Nutrition Examination Survey (NHANES III). NHANES III was designed as a cross-sectional study using a multistage-stratified, clustered probability sample of the U.S. civilian noninstitutionalized population.…”
mentioning
confidence: 99%
“…Recently, however, the link between androgen deficiency and atherosclerosis has been demonstrated in a number of studies. [8][9][10] Various epidemiological and experimental studies have also demonstrated that androgens exert beneficial influences on CVD via the direct and indirect action of androgens on the blood vessels.…”
Section: Introductionmentioning
confidence: 99%
“…But data are lacking as to whether higher testosterone levels predict reduced incidence of combined nonfatal and fatal major cardiovascular events [45]. The inverse correlation between T levels and the severity of coronary artery disease [46] may be related to the fact that low androgen levels are accompanied by an accumulation of abdominal visceral fat [47,48] associated with increased cardiovascular risk factors, impaired glucose tolerance, and non-insulindependent diabetes mellitus [49].…”
Section: Improving Metabolic Syndrome and Diabetes Type 2 Cardiovascmentioning
confidence: 99%
“…The administration of testosterone in physiological concentration increases coronary blood flow in patients with coronary heart disease [53]. Beneficial effects on endothelial function [54] and myocardial ischemia have also been demonstrated [46,55,56] but not on cardiovascular mortality [53,54]. Thus, although lower testosterone levels are associated with higher cardiovascular risk and to an extent with mortality in aging men, randomized controlled clinical trials of adequate size and duration are needed to determine whether testosterone therapy will reduce morbidity and mortality from cardiovascular disease in hypogonadal or eugonadal men.…”
Section: Improving Metabolic Syndrome and Diabetes Type 2 Cardiovascmentioning
confidence: 99%